Emergent BioSolutions EBS
NYSE EBS
$6.76 +0.21 (+3.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Emergent BioSolutions (EBS) Market Capitalization (2010 - 2026)

Emergent BioSolutions (EBS) posted Market Capitalization of $429.9 million for Q2 2026, little changed on a QoQ basis from $429.9 million in Q1 2026, and up 25.48% year-over-year from $342.6 million in Q2 2025.

Analysis

Emergent BioSolutions (EBS) Market Capitalization (2010 - 2026) Analysis & Trends

Emergent BioSolutions has reported Market Capitalization for 17 years, with the latest figure at $429.9 million in Q2 2026.

  • On a quarterly basis, Market Capitalization rose 25.48% year-over-year to $429.9 million in Q2 2026; TTM through Jun 2026 was $429.9 million, a 25.48% increase from a year earlier, with the FY2025 full-year figure at $644.0 million, up 24.05% from the prior year.
  • Market Capitalization was $429.9 million for Q2 2026 at Emergent BioSolutions, roughly flat from $429.9 million in the prior quarter.
  • The five-year high for Market Capitalization was $2.1 billion in Q1 2022, with the low at $125.3 million in Q4 2023.
  • Average Market Capitalization over 5 years is $583.4 million, with a median of $440.8 million recorded in 2024.
  • The sharpest annual moves came in 2023 and 2024: Market Capitalization tumbled 83.19% in 2023, then surged 314.36% in 2024.
  • Over 5 years, Market Capitalization stood at $591.7 million in 2022, then slumped by 78.83% to $125.3 million in 2023, then surged by 314.36% to $519.1 million in 2024, then grew by 24.05% to $644.0 million in 2025, then slumped by 33.24% to $429.9 million in 2026.
  • The last three Market Capitalization figures came in at $429.9 million (Q2 2026), $429.9 million (Q1 2026), and $644.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.47 Bn 628.71 Bn 17.26 Bn
2 AbbVie 467.46 Bn 460.93 Bn 12.70 Bn
3 Merck 369.31 Bn 362.22 Bn 12.21 Bn
4 Novartis Ag 269.03 Bn 261.74 Bn 11.24 Bn
5 Pfizer 158.11 Bn 146.71 Bn 10.94 Bn
6 Bristol Myers Squibb 127.96 Bn 116.89 Bn 9.25 Bn
7 Sanofi 51.83 Bn 44.86 Bn 10.79 Bn
8 BeOne Medicines 41.33 Bn 36.23 Bn 1.53 Bn
9 Revolution Medicines 41.30 Bn 41.30 Bn -
10 Emergent BioSolutions 335.50 Mn 194.60 Mn 137.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 429.89 Mn
Mar 31, 2026 429.94 Mn
Dec 31, 2025 643.96 Mn
Sep 30, 2025 464.81 Mn
Jun 30, 2025 342.61 Mn
Mar 31, 2025 264.87 Mn
Dec 31, 2024 519.11 Mn
Sep 30, 2024 451.74 Mn
Jun 30, 2024 360.78 Mn
Mar 31, 2024 132.57 Mn
Dec 31, 2023 125.28 Mn
Sep 30, 2023 176.12 Mn
Jun 30, 2023 380.73 Mn
Mar 31, 2023 522.14 Mn
Dec 31, 2022 591.68 Mn
Sep 30, 2022 1.05 Bn
Jun 30, 2022 1.55 Bn
Mar 31, 2022 2.07 Bn
Dec 31, 2021 2.23 Bn
Sep 30, 2021 2.69 Bn
API Access

Emergent BioSolutions Market Capitalization API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=market-capitalization&ticker=EBS&period=max&api_key=YOUR_API_KEY